Cancer chemotherapy impairs contextual but not cue-specific fear memory

Jill E. MacLeod, Joyce A. DeLeo, William F. Hickey, Tim A. Ahles, Andrew Saykin, David J. Bucci

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

This study examined the effects of a standard breast cancer chemotherapeutic protocol on learning and memory in rats. Ovariectomized rats were treated once a week for 3 weeks with a combination of cyclophosphamide and doxorubicin prior to training in a classical fear conditioning task. Training took place 1 week after the final treatment. During the training session, an auditory stimulus (a tone) was paired with a mild foot-shock. The resulting conditioned fear to the tone (cue-specific fear) and to the training environment (contextual fear) was measured in subsequent test sessions. Chemotherapy did not affect the acquisition of the conditioned response (freezing) during the training session or the expression of fear during the tone test session. In contrast, rats treated with cyclophosphamide and doxorubicin exhibited decreased freezing during the context test session, suggestive of a specific deficit in hippocampal-related learning and memory. Together, these data indicate that administration of cyclophosphamide and doxorubicin may have toxic effects on the hippocampus and results in specific learning deficits shortly after treatment has ended.

Original languageEnglish (US)
Pages (from-to)168-172
Number of pages5
JournalBehavioural Brain Research
Volume181
Issue number1
DOIs
StatePublished - Jul 19 2007
Externally publishedYes

Fingerprint

Fear
Cues
Drug Therapy
Doxorubicin
Cyclophosphamide
Learning
Neoplasms
Freezing
Classical Conditioning
Poisons
Foot
Shock
Hippocampus
Breast Neoplasms
Therapeutics

Keywords

  • Chemotherapy
  • Cyclophosphamide
  • Doxorubicin
  • Learning
  • Rat

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

MacLeod, J. E., DeLeo, J. A., Hickey, W. F., Ahles, T. A., Saykin, A., & Bucci, D. J. (2007). Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behavioural Brain Research, 181(1), 168-172. https://doi.org/10.1016/j.bbr.2007.04.003

Cancer chemotherapy impairs contextual but not cue-specific fear memory. / MacLeod, Jill E.; DeLeo, Joyce A.; Hickey, William F.; Ahles, Tim A.; Saykin, Andrew; Bucci, David J.

In: Behavioural Brain Research, Vol. 181, No. 1, 19.07.2007, p. 168-172.

Research output: Contribution to journalArticle

MacLeod, JE, DeLeo, JA, Hickey, WF, Ahles, TA, Saykin, A & Bucci, DJ 2007, 'Cancer chemotherapy impairs contextual but not cue-specific fear memory', Behavioural Brain Research, vol. 181, no. 1, pp. 168-172. https://doi.org/10.1016/j.bbr.2007.04.003
MacLeod, Jill E. ; DeLeo, Joyce A. ; Hickey, William F. ; Ahles, Tim A. ; Saykin, Andrew ; Bucci, David J. / Cancer chemotherapy impairs contextual but not cue-specific fear memory. In: Behavioural Brain Research. 2007 ; Vol. 181, No. 1. pp. 168-172.
@article{21385dba7dec4280b7ce88437a8b7792,
title = "Cancer chemotherapy impairs contextual but not cue-specific fear memory",
abstract = "This study examined the effects of a standard breast cancer chemotherapeutic protocol on learning and memory in rats. Ovariectomized rats were treated once a week for 3 weeks with a combination of cyclophosphamide and doxorubicin prior to training in a classical fear conditioning task. Training took place 1 week after the final treatment. During the training session, an auditory stimulus (a tone) was paired with a mild foot-shock. The resulting conditioned fear to the tone (cue-specific fear) and to the training environment (contextual fear) was measured in subsequent test sessions. Chemotherapy did not affect the acquisition of the conditioned response (freezing) during the training session or the expression of fear during the tone test session. In contrast, rats treated with cyclophosphamide and doxorubicin exhibited decreased freezing during the context test session, suggestive of a specific deficit in hippocampal-related learning and memory. Together, these data indicate that administration of cyclophosphamide and doxorubicin may have toxic effects on the hippocampus and results in specific learning deficits shortly after treatment has ended.",
keywords = "Chemotherapy, Cyclophosphamide, Doxorubicin, Learning, Rat",
author = "MacLeod, {Jill E.} and DeLeo, {Joyce A.} and Hickey, {William F.} and Ahles, {Tim A.} and Andrew Saykin and Bucci, {David J.}",
year = "2007",
month = "7",
day = "19",
doi = "10.1016/j.bbr.2007.04.003",
language = "English (US)",
volume = "181",
pages = "168--172",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Cancer chemotherapy impairs contextual but not cue-specific fear memory

AU - MacLeod, Jill E.

AU - DeLeo, Joyce A.

AU - Hickey, William F.

AU - Ahles, Tim A.

AU - Saykin, Andrew

AU - Bucci, David J.

PY - 2007/7/19

Y1 - 2007/7/19

N2 - This study examined the effects of a standard breast cancer chemotherapeutic protocol on learning and memory in rats. Ovariectomized rats were treated once a week for 3 weeks with a combination of cyclophosphamide and doxorubicin prior to training in a classical fear conditioning task. Training took place 1 week after the final treatment. During the training session, an auditory stimulus (a tone) was paired with a mild foot-shock. The resulting conditioned fear to the tone (cue-specific fear) and to the training environment (contextual fear) was measured in subsequent test sessions. Chemotherapy did not affect the acquisition of the conditioned response (freezing) during the training session or the expression of fear during the tone test session. In contrast, rats treated with cyclophosphamide and doxorubicin exhibited decreased freezing during the context test session, suggestive of a specific deficit in hippocampal-related learning and memory. Together, these data indicate that administration of cyclophosphamide and doxorubicin may have toxic effects on the hippocampus and results in specific learning deficits shortly after treatment has ended.

AB - This study examined the effects of a standard breast cancer chemotherapeutic protocol on learning and memory in rats. Ovariectomized rats were treated once a week for 3 weeks with a combination of cyclophosphamide and doxorubicin prior to training in a classical fear conditioning task. Training took place 1 week after the final treatment. During the training session, an auditory stimulus (a tone) was paired with a mild foot-shock. The resulting conditioned fear to the tone (cue-specific fear) and to the training environment (contextual fear) was measured in subsequent test sessions. Chemotherapy did not affect the acquisition of the conditioned response (freezing) during the training session or the expression of fear during the tone test session. In contrast, rats treated with cyclophosphamide and doxorubicin exhibited decreased freezing during the context test session, suggestive of a specific deficit in hippocampal-related learning and memory. Together, these data indicate that administration of cyclophosphamide and doxorubicin may have toxic effects on the hippocampus and results in specific learning deficits shortly after treatment has ended.

KW - Chemotherapy

KW - Cyclophosphamide

KW - Doxorubicin

KW - Learning

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=34248581978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248581978&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2007.04.003

DO - 10.1016/j.bbr.2007.04.003

M3 - Article

C2 - 17509697

AN - SCOPUS:34248581978

VL - 181

SP - 168

EP - 172

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1

ER -